ZEINA S TANNOUS, MD
Dermatology at Staniford St, Boston, MA
License number
Massachusetts 220731
Category
Osteopathic Medicine
Type
Dermatology
Address
Address
50 Staniford St FLOOR 2ND, Boston, MA 02114
Phone
(617) 724-6960
(617) 724-0287
(617) 726-2894 (Fax)
(617) 724-0287
(617) 726-2894 (Fax)
Personal information
See more information about ZEINA S TANNOUS at radaris.comName
Address
Phone
Boston, MA
6 Whittier St, Boston, MA 02114
1 Longfellow St, Boston, MA 02114
Professional information
Dr. Zeina S Tannous, Boston MA - MD (Doctor of Medicine)
Specialties:
Dermatopathology
Address:
Massachusetts General Hospital DER Assc
50 Staniford St SUITE 200, Boston 02114
(617) 726-2914 (Phone)
50 Staniford St SUITE 200, Boston 02114
(617) 726-2914 (Phone)
Certifications:
Dermatology, 2005, Dermatopathology, 2005
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Massachusetts General Hospital DER Assc
50 Staniford St SUITE 200, Boston 02114
Massachusetts General Hospital
55 Fruit St, Boston 02114
50 Staniford St SUITE 200, Boston 02114
Massachusetts General Hospital
55 Fruit St, Boston 02114
Education:
Medical School
American University Of Beirut, Faculty Of Medicine
Graduated: 1995
Caritas Carney Hospital
Mass Gen Hospital
Harvard University Health Services
American University Of Beirut, Faculty Of Medicine
Graduated: 1995
Caritas Carney Hospital
Mass Gen Hospital
Harvard University Health Services
Zeina S Tannous, Boston MA
Specialties:
Dermatology, Dermatopathology, Plastic Surgery
Work:
Dermatology Associates
50 Staniford St, Boston, MA 02114 Massachusetts General Hospital
55 Fruit St, Boston, MA 02114
50 Staniford St, Boston, MA 02114 Massachusetts General Hospital
55 Fruit St, Boston, MA 02114
Education:
American University Of Beirut (1995)
Methods And Compositions For Dose-Dependent Photodynamic Therapy Of Disorders
US Patent:
2009025, Oct 15, 2009
Filed:
Mar 23, 2009
Appl. No.:
12/409150
Inventors:
Fernanda H. Sakamoto - Boston MA, US
R. R. Anderson - Boston MA, US
Zeina Tannous - Boston MA, US
William A. Farinelli - Danvers MA, US
Apostolos G. Doukas - Belmont MA, US
R. R. Anderson - Boston MA, US
Zeina Tannous - Boston MA, US
William A. Farinelli - Danvers MA, US
Apostolos G. Doukas - Belmont MA, US
Assignee:
THE GENERAL HOSPITAL CORPORATION - Boston MA
International Classification:
A61N 5/06, A61K 31/197, A61P 35/00
US Classification:
604 21, 604 20, 514561
Abstract:
The invention provides methods and compositions for treating a tissue disorder in a subject by parenterally administering a solution of aminolevulinic acid (ALA) or a derivative thereof that is not greater than 1.0 percent by weight into a local subcutaneous or dermal region of the subject; and administering high fluence light to said bodily area to produce a phototoxic species in said local region, thereby treating a tissue disorder in the subject.
Contrast Enhancing Solution For Use In Confocal Microscopy
US Patent:
7128894, Oct 31, 2006
Filed:
Jun 27, 2003
Appl. No.:
10/607630
Inventors:
Zeina Tannous - Boston MA, US
Abel Torres - Loma Linda CA, US
Salvador González - Newton MA, US
Abel Torres - Loma Linda CA, US
Salvador González - Newton MA, US
Assignee:
The United States of America as represented by the United States Department of Energy - Washington DC
International Classification:
A61K 49/00
US Classification:
424 91
Abstract:
A method of optically detecting a tumor during surgery. The method includes imaging at least one test point defined on the tumor using a first optical imaging system to provide a first tumor image. The method further includes excising a first predetermined layer of the tumor for forming an in-vivo defect area. A predetermined contrast enhancing solution is disposed on the in-vivo defect area, which is adapted to interact with at least one cell anomaly, such as basal cell carcinoma, located on the in-vivo defect area for optically enhancing the cell anomaly. Thereafter the defect area can be optically imaged to provide a clear and bright representation of the cell anomaly to aid a surgeon while surgically removing the cell anomaly.